Prior authorization to manage drug utilization and costs

Framework for Pharmacy Services Quality Improvement-A Bridge to Cross the Quality Chasm.

Journal of managed care & specialty pharmacy·2020

How do seniors respond to 100% cost-sharing for prescription drugs? Quality of the evidence underlying opinions about the Medicare Part D coverage gap.

Journal of managed care pharmacy : JMCP·2011

What is the price benchmark to replace average wholesale price (AWP)?

Journal of managed care pharmacy : JMCP·2010

Should eligibility for medication therapy management be based on drug adherence?

Journal of managed care pharmacy : JMCP·2014

Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.

Journal of managed care pharmacy : JMCP·2014

PCMHs, ACOs, and medication management: lessons learned from early research partnerships.

Journal of managed care pharmacy : JMCP·2014

Adherence to national recommendations for safe methotrexate dispensing in community pharmacies.

Journal of managed care pharmacy : JMCP·2014

Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.

Journal of managed care pharmacy : JMCP·2014

Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.

Journal of managed care pharmacy : JMCP·2014

Navigating Chinese-led economic integration: a comparative study of commercial dispute resolution and public policy exceptions in Cambodia, Pakistan and Thailand.

Frontiers in sociology·2026

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease.

Movement disorders clinical practice·2026

AI product liability under EU and Canadian laws.

Frontiers in artificial intelligence·2026

[THE ACTUAL ISSUES OF MANDATORY LABELING OF MEDICAL ARTICLES].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026

Pharmaceutical Innovation and Drug Policy: The Case of the 1984 Hatch-Waxman Act.

PloS one·2026

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.

Neurourology and urodynamics·2026

Related Experiment Videos

Prior authorization to manage drug utilization and costs

Related Concept Videos

Framework for Pharmacy Services Quality Improvement-A Bridge to Cross the Quality Chasm.

How do seniors respond to 100% cost-sharing for prescription drugs? Quality of the evidence underlying opinions about the Medicare Part D coverage gap.

What is the price benchmark to replace average wholesale price (AWP)?

Should eligibility for medication therapy management be based on drug adherence?

Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.

PCMHs, ACOs, and medication management: lessons learned from early research partnerships.

Adherence to national recommendations for safe methotrexate dispensing in community pharmacies.

Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.

Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.

Navigating Chinese-led economic integration: a comparative study of commercial dispute resolution and public policy exceptions in Cambodia, Pakistan and Thailand.

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease.

AI product liability under EU and Canadian laws.

[THE ACTUAL ISSUES OF MANDATORY LABELING OF MEDICAL ARTICLES].

Pharmaceutical Innovation and Drug Policy: The Case of the 1984 Hatch-Waxman Act.

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.

Related Experiment Videos

Prior authorization to manage drug utilization and costs

Related Concept Videos

Related Articles